Ordering
Available Variants1 g
CHJ.42437-1g
Price
€58.56
Available – Dispatch in 14 days
5 g
CHJ.42437-5g
Price
€268.00
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
1 g | CHJ.42437-1g | €58.56 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 g | CHJ.42437-5g | €268.00 |
Professionally catalogued chemical listing prepared to support identification, technical review, safety visibility, and structured B2B sourcing workflows.
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C3H6N2O2 |
|---|---|
| CAS Number | 68-41-7 |
| Molecular Weight | 102.09 |
| UNSPSC Code | 51102829 |
| NACRES | NA.85 |
| PubChem Substance ID | 57648401 |
| EC Number | 200-688-4 |
| Beilstein/REAXYS Number | 80798 |
| MDL number | MFCD00005353 |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 2 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
| ppe | Eyeshields, Gloves, type N95 (US) |
Technical Overview & Applications Use-case context
D-Cycloserine, with a CAS number of 68-41-7, is an antibiotic that has been utilized in the treatment of tuberculosis. It functions by inhibiting cell wall synthesis in bacteria, ultimately leading to their death. As a second-line antitubercular agent, D-Cycloserine is often employed when primary treatments are ineffective. Its mechanism of action involves the competitive inhibition of alanine racemase and D-alanyl-D-alanine synthetase, enzymes essential for peptidoglycan synthesis in bacterial cell walls. D-Cycloserine is administered orally and is known to cross the blood-brain barrier, which can lead to neurological side effects. Monitoring of patients is necessary to minimize potential adverse effects, and it is typically used in combination with other antitubercular agents to enhance efficacy and reduce the risk of resistance development. The use of D-Cycloserine requires careful consideration due to its potential side effects and limited therapeutic window.
